FDA seeks active system for monitoring adverse events

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2008年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：14 / +
页数：2
相关论文
共 50 条
  • [1] Adverse Events of Desvenlafaxine Using FDA Adverse Events Reporting System
    Karydes, H. C.
    Leikin, J. B.
    CLINICAL TOXICOLOGY, 2010, 48 (06) : 664 - 664
  • [2] FDA unveils searchable adverse events system
    Asher Mullard
    Nature Reviews Drug Discovery, 2017, 16 : 743 - 743
  • [3] FDA unveils searchable adverse events system
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (11) : 743 - 743
  • [4] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [5] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [6] PHARMACOVIGILANCE ANALYSIS OF FDA ADVERSE EVENTS REPORTING SYSTEM FOR MAVACAMTEN
    Matai, Pallavi
    Amirian, Aslan
    Khadka, Sulochana
    Gavilanes, Diana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 560 - 560
  • [7] Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
    Wen, Ming-Tao
    Li, Jia-Cheng
    Lu, Bo-Wen
    Shao, Hua-Rong
    Ling, Pei-Xue
    Liu, Fei
    Li, Gang
    Luo, Di
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] FDA guidance document on monitoring delayed adverse events a good first start
    Williams, DA
    MOLECULAR THERAPY, 2005, 12 (06) : 991 - 992
  • [9] Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants
    Ehrenpreis, Eli D.
    Sifuentes, Humberto
    Ehrenpreis, Jamie E.
    Smith, Zachary L.
    Marshall, Mike L.
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (02) : 177 - 183
  • [10] Reporting Adverse Events for Cannabis to the FDA
    Hines, Michelle C.
    Harinstein, Lisa M.
    Kortepeter, Cindy M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 98 - 98
12345